Top 10 Stocks for 2026: Live Expert Analysis & Free Stock List

Successful investing requires the ability to identify opportunities that blend growth with stability. ProPicks AI (the same system that helped subscribers outperform the market in 2025) has identified ten stocks positioned for breakout performance in 2026. These stocks have been carefully selected for their growth potential – many of which are on a potential sector-rebound over the coming few years.

In an exclusive webinar, Asaf Rothem, Thomas Monteiro, and Lon Juricic from Investing.com, along with special guest Ricky Gutierrez, break down InvestingPro’s stock predictions for 2026, offering insights into the key factors that will shape the market. From the potential for further AI-driven growth to the looming challenges of higher regulatory shifts in data privacy and renewable/crude energy going head to head, these factors will undoubtedly influence stock performance throughout the year.

The consensus among Investing.com experts is that, while the market’s valuations are notably high, there still exists a wealth of opportunities for investors along with some interesting contrarian plays. Here’s what you need to know before the calendar flips to January:

Lon Juricic emphasizes the ongoing impact of AI, tariffs, and Federal Reserve policies as key themes. Despite initial declines, the S&P 500 rebounded impressively, with AI-driven data centers playing a critical role in this turnaround.

Major players like Nvidia, Google, and Broadcom significantly boosted the index, highlighting their influence in the market. Lon points to substantial growth in companies like Bloom Energies and Sandisk, which surged due to their involvement in AI technologies.

But here’s the shift: the impact of tariffs and government incentives is spurring domestic manufacturing, with companies such as Intel and MP Materials benefiting from these policies. However, Lon also warns of potential volatility, as evidenced by struggles in Bitcoin-related investments, illustrating broader market uncertainties. The Federal Reserve’s recent rate-cutting cycle has further shifted the landscape, affecting rate-sensitive sectors like financials and home builders.

Thomas Monteiro reflects on what he describes as an exceptionally opportunity-rich year. The market swung 30% from bottom to top—creating unusual volatility and hidden gems. He identifies the devaluation of the U.S. dollar, which spurred unexpected revenue growth for U.S.-based companies with overseas earnings, as a key factor in this year’s economic dynamics.

The AI sector is recalibrating. Monteiro discusses the ongoing shift from a focus on established giants like Nvidia to earlier-stage companies poised for growth. This repricing process, he notes, may introduce short-term pain but signals a broadening rather than a decline of opportunities in AI. Thomas highlights the role of interest rate expectations, with rates remaining higher than anticipated, and the political influence of incoming appointments under Trump as pivotal factors that could reshape the market in 2026.

Ricky Gutierrez notes that while 2025 has been rewarding, it also posed challenges, especially for beginner investors. The year’s success wasn’t solely reliant on fundamentals; rather, stocks with compelling narratives and strong price momentum significantly outperformed.

Ricky expresses caution about the potential of an AI bubble, questioning whether the momentum will sustain into 2026 or if companies that lack solid financial foundations might face a correction. With many newcomers focusing on rapid gains, Ricky stresses the importance of risk management by utilizing tools like InvestingPro to ensure investments are backed by both sound technical performance and fundamentals. He remains keen to observe whether the market will witness another growth cycle or if a corrective phase is on the horizon.

With these expert insights in mind, let’s reveal the opportunities most investors are missing.

ProPicks AI has sifted through the market to identify the top 10 stocks poised for growth in 2025. Here’s a rundown of five of its picks and why these stocks stand out:

Haemonetics Corporation had a challenging start in 2025 but posted a remarkable turnaround in the latter half of the year, gaining 62% in November alone. The company, specializing in medical supplies for blood-related procedures, experienced early declines due to high spending and product line updates, which affected its margins. However, with a successful transition now complete, Haemonetics is positioned with strong cash flows and a poised portfolio for the upcoming year.

Expert Insights

Thomas Monteiro took a personal interest in Haemonetics, identifying it as a high-conviction pick with substantial upside potential. Despite its recent surge, he considers the stock to be fairly valued, reflecting its blend of momentum and sound fundamentals.

“You have valuation, you have momentum, you have the narrative, you have everything combined,” Monteiro notes, highlighting the company’s successful narrative shift—combining valuation, growth potential, and solid financial performance. This balance of factors makes Haemonetics a compelling pick for investors looking ahead.

Key Takeaway: Strong cash flows meet momentum—a rare combination in today’s market.

Align Technology, known for its Invisalign dental system, has experienced a rough period, with the stock down 30% in 2025 and a significant drop of almost 70% over the last five years. Despite these challenges, the company shows signs of stabilization, particularly with growth in key markets across Europe, the Middle East, and Asia Pacific. Additionally, Align has seen an 8% year-over-year increase in the teens and kids segment.

Expert Insights

Lon Juricic acknowledges the difficulties faced by Align Technology but sees potential for recovery. Trading at 13 times next year’s earnings, the stock is dramatically undervalued compared to its historical trend of trading at 40 times earnings.

Lon suggests that a multiple revision to around 20 could result in a 40-50% increase in the stock’s value, even without additional earnings growth. While he agrees with AI that Align shows potential, Lon emphasizes the importance of continued stabilization and effective management execution to realize these gains.

Key Takeaway: A potential 40-50% upside from multiple expansion alone—if management executes.

Microchip Technology, headquartered in Arizona, has experienced a significant downturn in 2025, with its stock retracing 43% from its highs of $96 per share to lows of $53. Despite this recent decline, the company is poised for a potential rebound, driven by improving fundamentals and a possible resurgence in AI-driven market dynamics.

Expert Insights

Ricky Gutierrez is familiar with Microchip and highlights the potential for its recovery in 2026. While the company faced challenges this year, with a negative PE ratio of -118x and a net income loss of $185 million, analysts expect a return to profitability soon.

“If we have another leg up in this whole AI boom again, then Microchip can get a second wind and a true chance to actually do very well,” Ricky emphasizes. He advises cautious optimism, suggesting that investors monitor market conditions and sentiment shifts before committing heavily. Should the AI resurgence gain momentum, Microchip, with its established business model and potential for growth, could become a standout performer in 2026.

Key Takeaway: Beaten down but not broken—positioned for an AI-driven comeback.

Centene Corporation is a company primarily focused on managed care for Medicare, Medicaid, and the underinsured. 2025 has proved to be a challenging year, with its stock down 37% year-to-date following a significant profit warning. This has led to a major repricing and stabilization phase, positioning Centene as a potential value play amid a broader market shift.

Expert Insights

Lon Juricic sees Centene as an intriguing trough earnings play, suggesting that its earnings are at a low point with potential for recovery. While the company has undergone considerable cuts and guidance revisions, the foundation is set for margin recovery.

The long game comes from its earnings per share being projected to grow from $2 in 2027 to potentially $9 by 2029. He advises cautious entry, recommending investors consider gradually investing in Centene over the next year in anticipation of future earnings power and market multiple improvements. This makes Centene a compelling choice for long-term, value-focused investors.

Key Takeaway: EPS could jump from $2 to $9 by 2029—institutional money is already positioning.

It’s interesting at this point to show the highlighted shift from 2025’s focus on aggressive growth strategies to companies showing potential for traditional profitability and value generation. This is arguably a return to more ‘old school’ business principles, where companies concentrate on turning around their fortunes and improving shareholder value. 

So does the healthcare sector’s beaten-down state signify a sector-wide recovery, or should investors simply look at company-specific opportunities? It’s true that many healthcare companies, after a turbulent year, are now starting to stabilize their earnings (particularly in companies like Centene), which presents a pathway to the normalization of profits and onwards to lucrative investment opportunities.

Unlike the list for the Top 10 2025 Stocks, there definitely seems to be more of a trend in 2026 toward smaller market capitalization stocks in current AI-driven selections compared to past heavier hitters like Intel.

Okay – back to the list!

Peabody Energy has experienced a 30% increase in value year-to-date (as of December 1st), despite reporting a net loss of $17.1 million against a revenue of $3.9 billion. The company is currently trading at a negative multiple of -104.3x its earnings, reflecting speculative valuations in its sector.

Expert Insights

Ricky notes the speculative nature of Peabody Energy’s valuation, highlighting its performance amid favorable market conditions for certain sectors. He observes that while Peabody has shown strong gains, its financial metrics suggest an environment of speculative valuation rather than traditional profitability.

If market uncertainties persist, Peabody’s stock may face retracement to lower levels, potentially between $10 to $16 per share. Conversely, if bullish momentum continues into 2026, Peabody might remain a viable watchlist candidate for investors expecting sustained growth in speculative markets. Ricky stresses the importance of aligning investment strategies with market trends when considering Peabody’s future prospects.

Key Takeaway: High-risk, high-reward speculation play—position size accordingly.

Victoria’s Secret has faced significant volatility due to its struggles in adapting to shifting consumer behaviors and market dynamics. While the well-known consumer brand has made attempts at a turnaround, challenges remain as it seeks to regain its once-strong marketing and brand value.

Expert Insights

Thomas Monteiro highlights the difficulties Victoria’s Secret faces as it navigates changing consumer trends, particularly the shift from physical retail to digital platforms. Despite some momentum in its turnaround, including efforts to refresh its brand and capitalize on recent trends, Thomas remains skeptical of its potential given the volatile macro environment and uncertainties in key markets. He notes a wide disparity in analyst expectations, reflecting varied opinions on the company’s future performance.

Lon Juricic mentions the potential impact of cultural trends, like the “Sydney Sweeney effect,” referencing a possible return to traditional marketing strategies that emphasize the brand’s iconic imagery. He suggests that while these efforts might tempt the InvestingPro AI to consider Victoria’s Secret a viable opportunity, the overall reliance on such factors introduces considerable unpredictability.

Asaf concludes by acknowledging the stock’s inclusion in AI-generated picks due to its potential upside, yet he cautions about the high uncertainty and variability in forecasts. While the stock offers diversity within investment portfolios, it’s important to recognize the low confidence level associated with this play, given the numerous factors that would need to align for success.

Key Takeaway: High uncertainty, high potential—only for diversified portfolios with risk tolerance.

Huntington Ingalls Industries is a leading builder of aircraft carriers and nuclear submarines. This stock aligns with ongoing global defense priorities, particularly under policies favoring a robust U.S. Navy. The company’s strategic positioning in the defense sector has allowed it to post record revenues, with a favorable outlook given current geopolitical tensions and government defense spending.

Expert Insights

Lon Juricic highlights the strategic advantage Huntington Ingalls holds amid increased global defense expenditures, partly influenced by the Ukraine-Russia conflict and Middle East tensions. The company’s expertise in shipbuilding directly supports Trump’s ambitions for a stronger U.S. military. Analysts expect low to mid-teen earnings per share growth in the coming years, and despite a 63% rise in stock value year-to-date, its valuation remains attractive with a PE multiple of 22, slightly below the market average. Lon sees this as a promising addition to a diversified investment portfolio.

Asaf adds that Huntington Ingalls benefits from substantial, long-term government contracts once secured, therefore offering a stable revenue stream. This characteristic makes it an appealing choice for investors seeking exposure to the defense sector without excessive volatility.

Key Takeaway: Geopolitical tailwinds + long-term government contracts = stable growth in uncertain times.

ON Semiconductor has faced a challenging 2025, with its stock down 20% year-to-date amidst a persistent decline in revenue since mid-2023. Despite expectations for stronger performance in the robust semiconductor market, the company faces ongoing hurdles that may present opportunities if conditions shift favorably.

Expert Insights

Ricky highlights the company’s prolonged sell-off over the past two and a half years and emphasizes the need for a turnaround in both revenue and fundamentals to justify investment. While there’s an 11% upside indicated by fair value estimates, the current PE ratio of 63.6 times earnings and declining net income signal caution.

Thomas Monteiro views ON Semiconductor as an intriguing contrarian play, drawing parallels with broader trends in contrarian investing within the AI sector. He suggests that as investors reconsider their allocations and potentially move capital away from established AI leaders like Nvidia, ON Semiconductor might garner attention as a high-growth potential option in a different phase of its cycle. While its progress has lagged compared to initial expectations, Thomas remains open to the possibility that 2026 could mark a turning point.

Key Takeaway: Contrarian AI play—potential rotation candidate as money moves from mega-caps.

Venture Global Inc stands out as a significant turnaround candidate, having been severely impacted by a 70% decline in stock value this year. The company invested heavily in modernizing its infrastructure which, timed unfavorably with higher-than-expected interest rates, compounded its financial strain. However, it now appears poised to benefit from its completed infrastructure upgrades and potential improvements in interest rate environments.

Expert Insights

Thomas Monteiro describes Venture Global as the ultimate turnaround play, noting that its significant capital expenditures to adapt to the LNG market have created a challenging debt burden. The company now has a robust infrastructure and backlog, ready to leverage its potential in a growing LNG market, a sector catalyzed by global shifts following conflicts like the Ukraine-Russia war. Thomas supports the AI’s choice, highlighting the company as a hidden gem that may double in value given a more favorable interest rate environment, especially if future policy changes drive financing costs lower.

Asaf adds depth to this narrative, recognizing the complexity and effort required for companies with substantial physical infrastructure to adapt and transform. Successful turnarounds such as this can lead to significant valuation increases, underscoring the importance of strategic adaptation in challenging market conditions.

Key Takeaway: Infrastructure complete, debt burden easing—potential 100% upside if rates cooperate.

Molina Healthcare, closely related to Centene as a competitor in the healthcare sector, takes the top spot. The company has experienced significant declines, positioning it as a potential recovery play. The company is involved in providing managed care services, primarily focusing on Medicare and Medicaid.

Expert Insights

Lon Juricic draws parallels between Molina Healthcare and Centene, noting similar challenges with pricing and earnings expectations. He highlights Molina’s potential for earnings growth over the next few years, suggesting that investors could see earnings double from their current levels by 2029. Lon advises a scaled investment approach, given Molina’s current undervaluation and the anticipated recovery trajectory.

Ricky emphasizes the company’s low PE ratio of 8.4 times earnings and finds its revenue growth appealing despite the stock’s decline. He appreciates how AI surfaces such opportunities, allowing investors to discover undervalued stocks they might otherwise overlook. Ricky suggests setting alerts and monitoring the broader healthcare sector for signs of an uptick, which could present Molina as a strong investment option with a 40% potential upside.

Thomas Monteiro underscores the distinction between monthly and long-term investment strategies, cautioning that Molina Healthcare may not be suitable for quick returns due to its complex macroeconomic and political factors. He argues that Molina represents a disconnected relationship between earnings potential and stock price, offering a compelling long-term value. Thomas stresses the importance of employing advanced analytical tools, like AI, which utilize a broad range of financial models, to unearth such undervalued opportunities.

The consensus is that Molina Healthcare offers substantial long-term potential, though investors should be prepared for a multi-year investment horizon to fully realize gains as the company’s earnings and valuation recover.

Key Takeaway: #1 pick for a reason—40% upside potential with earnings poised to double by 2029.

Looking ahead to 2026, certain sectors are positioning for breakout growth after some rough months and ongoing bearish rumors. AI, defense, and healthcare are setting up to drive returns. The stocks highlighted in this list provide a mix of high growth potential and reversal-value, positioning them as top picks for investors looking to capitalize on these trends before institutional buying accelerates.

While the market remains volatile, finding a solid strategy for stock picking remains crucial. Investors should focus on undervalued opportunities and companies leveraging AI to improve efficiency and profitability.

If you’re looking for more tools to enhance your investment strategy, check out InvestingPro’s Warren AI, a game-changing research assistant that compiles real-time financial data, giving you answers in seconds that would take hours of manual research.

The difference between 2026’s winners and losers will be decided in the coming few weeks, as smart money starts to position itself ahead of the herd.

The year ahead promises both challenges and opportunities across most sectors, especially as geopolitical events and technological advancement, thanks to AI, show no signs of calming down. By focusing on key trends like AI, healthcare, and defense, investors can position themselves for success.

But here’s the reality: Reading about these stocks is one thing. Having the tools to monitor them, receive alerts on entry points, and access real-time analysis is another.

ProPicks AI has already identified the outliers. The question is: will you be positioned before the crowd figures it out?

Stay informed, stay tactical, and get positioned for 2026.